With the analysis among 72,627 patents, we discovered top 463 key players by total patent application. Novartis AG, F. Hoffmann-La Roche Ltd., Incyte Corp. are dominant in this area. They take 8.06% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 2,048
F. Hoffmann-La Roche Ltd.
Delaware, United States
Patent: 1,876
New York, United States
Patent: 1,667
Indiana, United States
Patent: 1,665
Incyte Pharmaceuticals, Inc.
California, United States
Patent: 1,581
Human Genome Sciences, Inc.
United States
Patent: 1,479
New York, United States
Patent: 1,441
California, United States
Patent: 1,192
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 1,034
With the analysis among 1,519 patents, we discovered top 153 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Delinia, Inc., CuraSen Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 63
CuraSen Therapeutics, Inc.
California, United States
Patent: 60
New York, United States
Patent: 59
Concentric Analgesics, Inc.
California, United States
Patent: 47
Primmune Therapeutics, Inc.
California, United States
Patent: 35
Schwyz, Switzerland
Patent: 29
Intarcia Therapeutics, Inc.
California, United States
Patent: 24
ImmuneSensor Therapeutics, Inc.
Texas, United States
Patent: 23
With the analysis among related 13,992 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Bristol Myers Squibb Co., Eli Lilly & Co., Novartis AG take 8.23% of patent filing during this period.
New York, United States
Patent: 472
Indiana, United States
Patent: 379
Basel-Stadt, Switzerland
Patent: 300
F. Hoffmann-La Roche Ltd.
Hovedstaden, Denmark
Patent: 175
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 174
California, United States
Patent: 166
California, United States
Patent: 154
Hanmi Pharmaceutical Co., Ltd.
With the analysis among related 13,992 patents in last 5 years, we discover 165 new entrants. BeiGene Ltd., CuraSen Therapeutics, Inc., Kallyope, Inc. are the most active new entrants in this area.
Massachusetts, United States
Patent: 67
CuraSen Therapeutics, Inc.
California, United States
Patent: 60
New York, United States
Patent: 59
California, United States
Patent: 58
Shanghai Qilu Ruige Pharmaceutical R&D Co. Ltd.
Shanghai Shi, China
Patent: 48
Terns Pharmaceuticals, Inc.
California, United States
Patent: 40
undefined undefined
Patent: 39
Primmune Therapeutics, Inc.
California, United States
Patent: 35
Massachusetts, United States
Patent: 34
California, United States
Patent: 34
With the analysis among 12,043 patents, we discovered top 239 universities and scientific research institutions by total patent application. The Salk Institute for Biological Studies, The Johns Hopkins University, University of Southern California are dominant in this area. They take 13.21% of the total patent filing.
The Salk Institute for Biological Studies
California, United States
Patent: 217
The Johns Hopkins University
University of Southern California
California, United States
Patent: 174
The Scripps Research Institute
California, United States
Patent: 160
North Carolina, United States
Patent: 154
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 148
Shanghai Shi, China
Patent: 125
Connecticut, United States
Patent: 123
Washington, United States
Patent: 122
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 110